Cargando…
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
BACKGROUND AND AIMS: Histone deacetylase inhibitors [HDACi] exert potent anti-inflammatory effects. Because of the ubiquitous expression of HDACs, clinical utility of HDACi is limited by off-target effects. Esterase-sensitive motif [ESM] technology aims to deliver ESM-conjugated compounds to human m...
Autores principales: | Elfiky, Ahmed M I, Ghiboub, Mohammed, Li Yim, Andrew Y F, Hageman, Ishtu L, Verhoeff, Jan, de Krijger, Manon, van Hamersveld, Patricia H P, Welting, Olaf, Admiraal, Iris, Rahman, Shafaque, Garcia-Vallejo, Juan J, Wildenberg, Manon E, Tomlinson, Laura, Gregory, Richard, Rioja, Inmaculada, Prinjha, Rab K, Furze, Rebecca C, Lewis, Huw D, Mander, Palwinder K, Heinsbroek, Sigrid E M, Bell, Matthew J, de Jonge, Wouter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089418/ https://www.ncbi.nlm.nih.gov/pubmed/34633041 http://dx.doi.org/10.1093/ecco-jcc/jjab176 |
Ejemplares similares
-
A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
por: Elfiky, Ahmed M. I., et al.
Publicado: (2022) -
Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022) -
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis
por: De Vries, Leonie C S, et al.
Publicado: (2020) -
BET Inhibition Improves NASH and Liver Fibrosis
por: Middleton, Sarah A., et al.
Publicado: (2018) -
Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis
por: Luque-Martin, Rosario, et al.
Publicado: (2019)